微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 2.19% | 57.55% | 1360% | 27/51 | 3.32% | 澳洋健康 | 34.16% | 行业排名> |
| 2024-06-30 | 0.15% | 650% | -85% | 34/51 | 2.09% | 澳洋健康 | 30.56% | 行业排名> |
| 2024-03-31 | 1% | 238.89% | 284.62% | 25/51 | 1.19% | 澳洋健康 | 28.14% | 行业排名> |
| 2023-12-31 | 0.26% | -72.34% | -81.29% | 37/51 | 3.73% | 澳洋健康 | 39.54% | 行业排名> |
| 2023-09-30 | 1.39% | 73.75% | 6850% | 39/51 | 6.82% | 澳洋健康 | 61.84% | 行业排名> |
| 2023-06-30 | 0.02% | 102.13% | 102.78% | 39/51 | 1.93% | 澳洋健康 | 48.34% | 行业排名> |
| 2023-03-31 | -0.72% | -33.33% | -176.6% | 39/51 | 2.58% | 澳洋健康 | 58.19% | 行业排名> |
| 2022-12-31 | 0.94% | -47.78% | 17.5% | 36/51 | -0.62% | *ST宜康 | 75.53% | 行业排名> |
| 2022-09-30 | 0.8% | -65.37% | 185.11% | 38/51 | 11.4% | 博腾股份 | 39.77% | 行业排名> |
| 2022-06-30 | -0.94% | -203.3% | -74.07% | 41/51 | 5.56% | 睿智医药 | 41.16% | 行业排名> |
| 2022-03-31 | -0.54% | -220% | -130% | 38/51 | 3.14% | 澳洋健康 | 51.68% | 行业排名> |
| 2021-12-31 | 1.8% | -57.14% | -22.08% | 36/51 | -6.68% | 澳洋健康 | 40.93% | 行业排名> |
| 2021-09-30 | 2.31% | 45.28% | 153.85% | 27/51 | 2.3% | 金域医学 | 43.58% | 行业排名> |
| 2021-06-30 | 0.91% | -24.79% | 102.22% | 36/51 | 2.28% | 金域医学 | 35.41% | 行业排名> |
| 2021-03-31 | 0.45% | -73.37% | -89.29% | 24/51 | 1.79% | 阳光诺和 | 26.2% | 行业排名> |
| 2020-12-31 | 4.2% | -74.5% | 164.15% | 36/51 | 10.95% | 金域医学 | 13.23% | 行业排名> |
| 2020-09-30 | 1.59% | -90.87% | 31.4% | 24/51 | 7.83% | 万邦医药 | 52.05% | 行业排名> |
| 2020-06-30 | 1.21% | -71.86% | -28.4% | 28/51 | 2.48% | 华大基因 | 48.52% | 行业排名> |
| 2020-03-31 | 1.69% | -19.52% | -89.74% | 10/51 | -0.22% | 华大基因 | 31.24% | 行业排名> |
| 2019-12-31 | 16.47% | 2% | -5.4% | 17/51 | 65.31% | 阳光诺和 | 13.99% | 行业排名> |
| 2019-09-30 | 17.41% | 2% | 304.88% | 5/51 | 10.68% | 南华生物 | 2848.07% | 行业排名> |
| 2019-06-30 | 4.3% | 2% | 104.76% | 15/51 | 5.65% | 南华生物 | 98.98% | 行业排名> |
| 2019-03-31 | 2.1% | 2% | 2% | 12/51 | 3.54% | 南华生物 | 82.46% | 行业排名> |